EFFECTS OF CULTURE MEDIA ON THE INVITRO SUSCEPTIBILITY OF SELECTED OPPORTUNISTIC FUNGI TO FLUCONAZOLE AND ITRACONAZOLE

被引:9
作者
SEKHON, AS [1 ]
PADHYE, AA [1 ]
GARG, AK [1 ]
HAMIR, Z [1 ]
机构
[1] CTR DIS CONTROL,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA 30333
关键词
INVITRO SUSCEPTIBILITY; FLUCONAZOLE; ITRACONAZOLE; ASPERGILLUS SPP; PSEUDALLESCHERIA-BOYDII; ALTERNARIA-ALTERNATA; XYLOHYPHA-BANTIANA;
D O I
10.1159/000238958
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The sensitivity of 23 isolates of opportunistic fungi, Aspergillus fumigatus (5), A. flavus (5), A. niger (5), Pseudallescheria boydii (5), Alternaria alternata (2) and Xylohypha bantiana (1), was investigated against fluconazole and itraconazole, using Sabouraud's dextrose broth (SD) and a high-resolution (HR) medium (Pfizer, Inc.). The procedure followed was a standard tube dilution (1 ml/tube) method. Candida albicans YO1 09 was included as reference strain to monitor quality and reproducibility. Results indicated that the minimal inhibitory concentrations (MICs) of fluconazole for all Aspergillus spp. and C albicans were greater-than-or-equal-to 100-mu-g/ml in SD medium, whereas, for P. boydi, A. alternata and X bantiana, the MICs were 50-mu-g/l. The MICs of itraconazole in SD medium were < 0.195-1.56-mu-g/ml for the fungi tested. In HR medium, the MICs of fluconazole for the Aspergillus spp, were greater-than-or-equal-to 100-mu-g/ml, and those for P. boydii, A. alternata and X. bantiana were 0.78,50 and 50-mu-g/ml, respectively. The MICs of itraconazole for all fungi ranged from < 0.198 to 0.78-mu-g/ml in the HR medium. The values for the reference strain were 1.56 and 100-mu-g/ml in the HR medium for fluconazole and itraconazole, respectively. The HR medium was more suitable for testing P boydii against fluconazole. This culture medium did not appear to significantly affect the MICs of itraconazole as compared to those of fluconazole, for the fungi investigated.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 17 条
[1]   FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID - IMPLICATIONS FOR TREATING FUNGAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM [J].
ARNDT, CAS ;
WALSH, TJ ;
MCCULLY, CL ;
BALIS, FM ;
PIZZO, PA ;
POPLACK, DG .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) :178-180
[2]  
BENNETT JE, 1990, FLUCONAZOLE OVERVIEW, P7
[3]  
Cutsem J. van, 1991, Journal de Mycologie Medicale, V1, P10
[4]  
Esposito R., 1989, Opportunistic fungal infections: focus on fluconazole. Proceedings of an International Symposium held in Lisbon on February 15, 1988., P47
[5]   IMPROVED METHOD FOR AZOLE ANTIFUNGAL SUSCEPTIBILITY TESTING [J].
GORDON, MA ;
LAPA, EW ;
PASSERO, PG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (09) :1874-1877
[6]   ITRACONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1989, 37 (03) :310-344
[7]  
Graybill J. R., 1989, Diagnosis and therapy of systemic fungal infections., P133
[8]  
MARRIOTT MS, 1987, RECENT TRENDS DISCOV, P18
[9]   INVITRO SUSCEPTIBILITY OF 119 YEAST ISOLATES TO FLUCONAZOLE, 5-FLUOROCYTOSINE, AMPHOTERICIN-B AND KETOCONAZOLE [J].
MORACE, G ;
MANZARA, S ;
DETTORI, G .
CHEMOTHERAPY, 1991, 37 (01) :23-31
[10]   INVITRO GROWTH INHIBITORY STUDIES OF PHACIDIN AGAINST SOME DERMATOPHYTES, OPPORTUNISTIC AND SYSTEMIC FUNGI, AND YEASTS PATHOGENIC ON MAN [J].
SEKHON, AS ;
FUNK, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (01) :95-100